Oxidative Stress, Mitochondrial Hormesis, and Hyperbaric Therapy in Autism
Oxidative stress and mitochondrial dysfunction are fundamental problems in autism. Although known to be damaging, oxidative stress is also an important cellular signal for mitochondria to adapt (mitochondrial hormesis.) Hyperbaric therapy has been shown to be beneficial in the treatment of autism, but its exact mechanism is unclear. This talk examines the effects of hyperbaric therapy on mitochondria and its use in autism and proposes mitochondrial hormesis as a possible mechanism.
Kyle Van Dyke, MD
Kyle Van Dyke recieved his MD from the University of Chicago and completed his redsidency in Family Medicine at the University of Virginia. He is board certified in Family Medicine. He became involved in autism after the diagnosis of his son 7 years ago. His interests include clinical interventions, mitochondria, and hyperbaric therapy.
